Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors

Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors

US Patent 10519181 · Granted Dec 31, 2019

Estimated economic value: $4,904,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

E-selectin antagonist compounds, compositions, and methods of use2024
E-selectin antagonist compounds, compositions, and methods of use2024
Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists2024
Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists2024
Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists2024
Galectin-3 inhibiting c-glycosides2024
Galectin-3 inhibiting c-glycosides2024
Galectin-3 inhibiting c-glycosides2024
Heterobifunctional inhibitors of E-selectin and galectin-32023
Heterobifunctional inhibitors of E-selectin and galectin-32023
Heterobifunctional inhibitors of E-selectin and galectin-32023
Highly potent multimeric e-selectin antagonists2023